Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October 6 University, Giza, 12585, Egypt.
Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt.
AAPS PharmSciTech. 2022 Jul 28;23(6):206. doi: 10.1208/s12249-022-02357-y.
Fungal infections are considered one of the most serious conditions as their occurrence has increased lately. Fungi like Candida, Fusarium, and Aspergillus species mostly affect immunocompromised patients as they are considered opportunistic pathogens. These infections can be superficial, cutaneous, subcutaneous, or systemic fungal infections that require specific treatment. There is a wide variety of antifungal drugs that can be used to cure fungal infections; however, most of them have many systemic side effects due to their physicochemical characteristics and high toxicity profile. Hence, the current review focuses on various advanced vesicular carriers with high biocompatibility that can encapsulate the antifungal drugs owing to increase their efficacy and limit the undesirable side effects. These advanced systems can manage stability, solubility, bioavailability, safety, and effectiveness issues present in conventional systems.
真菌感染被认为是最严重的疾病之一,因为它们的发生最近有所增加。像念珠菌、镰刀菌和曲霉菌属这样的真菌主要影响免疫功能低下的患者,因为它们被认为是机会性病原体。这些感染可以是浅表、皮肤、皮下或系统性真菌感染,需要特定的治疗。有各种各样的抗真菌药物可以用来治疗真菌感染;然而,由于它们的物理化学特性和高毒性特征,它们中的大多数都有许多全身性副作用。因此,本综述重点介绍了各种具有高生物相容性的先进囊泡载体,这些载体可以包裹抗真菌药物,从而提高其疗效并限制不良副作用。这些先进系统可以解决常规系统中存在的稳定性、溶解性、生物利用度、安全性和有效性问题。